Table 4.
Covariate | Successful | Lost to follow-up (95% CI) | Unknown (95% CI) | Unsuccessful (95% CI) |
---|---|---|---|---|
Intercept | – | 0.087 (0.052–0.144)* | 0.03 (0.017–0.055)* | 0.008 (0.003–0.02)* |
Months after outbreak | – | 0.953 (0.922–0.984)* | 1.179 (1.157–1.203)* | 1.034 (1.007–1.062)* |
Age | – | 1.018 (1.007–1.029)* | 1.014 (1.002–1.026)* | 1.044 (1.026–1.063)* |
HIV negative | – | – | – | – |
HIV not tested | – | 1.175 (0.442–3.125) | 3.291 (1.179–9.184)* | 5.095 (1.103–23.534)* |
HIV-positive | – | 3.852 (1.262–11.756)* | 1.48 (0.414–5.29) | 11.942 (2.969–48.028)* |
Active TB | – | – | – | – |
Latent TB | – | 2.029 (1.421–2.898)* | 1.612 (1.112–2.338)* | 1.662 (1.057–2.615)* |
Age × HIV negative | – | – | – | – |
Age × HIV not tested | – | 1.021 (0.998–1.044) | 0.987 (0.96–1.015) | 0.996 (0.966–1.028) |
Age × HIV positive | – | 0.967 (0.938–0.996)* | 0.981 (0.95–1.012) | 0.973 (0.943–1.003) |
Represents a statistically significant odds ratio (P < 0.05) indicating an association between the covariate and outcome, using a 95% CI.